{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:01:46Z","timestamp":1789646506405,"version":"4.0.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T00:00:00Z","timestamp":1684627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T00:00:00Z","timestamp":1684627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","award":["RSP-2023R353"],"award-info":[{"award-number":["RSP-2023R353"]}],"id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s43440-023-00495-z","type":"journal-article","created":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T12:01:12Z","timestamp":1684670472000},"page":"962-978","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Antiviral activity of some benzo[g]quinazolines against coxsackievirus B4: biological screening and docking study"],"prefix":"10.1007","volume":"75","author":[{"given":"Hatem A.","family":"Abuelizz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed H.","family":"Bakheit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Marzouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waled M.","family":"El-Senousy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed M.","family":"Abdellatif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamal A. E.","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quaiser","family":"Saquib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawsan B.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1747-2736","authenticated-orcid":false,"given":"Rashad","family":"Al-Salahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,21]]},"reference":[{"key":"495_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1006\/viro.2000.0801","volume":"281","author":"M Flodstr\u00f6m","year":"2001","unstructured":"Flodstr\u00f6m M, Horwitz MS, Maday A, Balakrishna D, Rodriguez E, Sarvetnick N. A critical role for inducible nitric oxide synthase in host survival following coxsackievirus B4 infection. Virology. 2001;281:205\u201315.","journal-title":"Virology"},{"key":"495_CR2","doi-asserted-by":"crossref","unstructured":"Chapman NM, Ramsingh AI, Tracy S. Genetics of coxsackievirus virulence. Coxsackie B Viruses 1997:227\u201358.","DOI":"10.1007\/978-3-642-60687-8_11"},{"key":"495_CR3","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.3390\/microorganisms8111790","volume":"8","author":"A Honkimaa","year":"2020","unstructured":"Honkimaa A, Kimura B, Sioofy-Khojine A-B, Lin J, Laiho J, Oikarinen S, et al. Genetic adaptation of coxsackievirus B1 during persistent infection in pancreatic cells. Microorganisms. 2020;8:1790.","journal-title":"Microorganisms"},{"key":"495_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1574-6976.2002.tb00601.x","volume":"26","author":"PC McMinn","year":"2002","unstructured":"McMinn PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev. 2002;26:91\u2013107.","journal-title":"FEMS Microbiol Rev"},{"key":"495_CR5","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1021\/acsomega.9b03706","volume":"5","author":"RA Azzam","year":"2020","unstructured":"Azzam RA, Osman RR, Elgemeie GH. Efficient synthesis and docking studies of novel benzothiazole-based pyrimidinesulfonamide scaffolds as new antiviral agents and Hsp90\u03b1 inhibitors. ACS Omega. 2020;5:1640\u201355.","journal-title":"ACS Omega"},{"key":"495_CR6","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3390\/microorganisms9061125","volume":"9","author":"MP Nekoua","year":"2021","unstructured":"Nekoua MP, Bertin A, Sane F, Gimeno J-P, Fournier I, Salzet M, et al. Persistence of coxsackievirus B4 in pancreatic \u03b2 cells disturbs insulin maturation, pattern of cellular proteins, and DNA methylation. Microorganisms. 2021;9:1125.","journal-title":"Microorganisms"},{"key":"495_CR7","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.idc.2010.07.001","volume":"24","author":"L Strasfeld","year":"2010","unstructured":"Strasfeld L, Chou S. Antiviral drug resistance: mechanisms and clinical implications. Infect Dis Clin. 2010;24:809\u201333.","journal-title":"Infect Dis Clin"},{"key":"495_CR8","doi-asserted-by":"publisher","first-page":"7782","DOI":"10.1128\/AAC.01375-15","volume":"59","author":"L Sun","year":"2015","unstructured":"Sun L, Meijer A, Froeyen M, Zhang L, Thibaut HJ, Baggen J, et al. Antiviral activity of broad-spectrum and enterovirus-specific inhibitors against clinical isolates of enterovirus D68. Antimicrob Agents Chemother. 2015;59:7782\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"495_CR9","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/jmv.21016","volume":"80","author":"F Brilot","year":"2008","unstructured":"Brilot F, Ja\u00efdane H, Geenen V, Hober D. Coxsackievirus B4 infection of murine foetal thymus organ cultures. J Med Virol. 2008;80:659\u201366.","journal-title":"J Med Virol"},{"key":"495_CR10","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.1073\/pnas.0700442104","volume":"104","author":"F Dotta","year":"2007","unstructured":"Dotta F, Censini S, van Halteren AGS, Marselli L, Masini M, Dionisi S, et al. Coxsackie B4 virus infection of \u03b2 cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci. 2007;104:5115\u201320.","journal-title":"Proc Natl Acad Sci"},{"key":"495_CR11","doi-asserted-by":"publisher","first-page":"6523","DOI":"10.1021\/jm058225d","volume":"48","author":"R Morphy","year":"2005","unstructured":"Morphy R, Rankovic Z. Designed multiple ligands. An emerging drug discovery paradigm. J Med Chem. 2005;48:6523\u201343.","journal-title":"J Med Chem"},{"key":"495_CR12","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.virusres.2010.02.017","volume":"150","author":"EL Tan","year":"2010","unstructured":"Tan EL, Wong APY, Poh CL. Development of potential antiviral strategy against coxsackievirus B4. Virus Res. 2010;150:85\u201392.","journal-title":"Virus Res"},{"key":"495_CR13","doi-asserted-by":"publisher","DOI":"10.1128\/genomeA.01125-17","author":"H Bixing","year":"2017","unstructured":"Bixing H, Harrower B, Burtonclay P, Constantino T, Warrilow D. Genome sequences of Coxsackievirus B5 isolates from two children with meningitis in Australia. Microbiol Resour Announc. 2017. https:\/\/doi.org\/10.1128\/genomeA.01125-17.","journal-title":"Microbiol Resour Announc"},{"key":"495_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/82_2010_37","volume-title":"Picornaviruses. Cell entry by non-enveloped viruses","author":"TJ Tuthill","year":"2010","unstructured":"Tuthill TJ, Groppelli E, Hogle JM, Rowlands DJ. Picornaviruses. Cell entry by non-enveloped viruses. Berlin: Springer; 2010. p. 43\u201389."},{"key":"495_CR15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3390\/v12040399","volume":"12","author":"OI Olasunkanmi","year":"2020","unstructured":"Olasunkanmi OI, Chen S, Mageto J, Zhong Z. Virus-induced cytoplasmic aggregates and inclusions are critical cellular regulatory and antiviral factors. Viruses. 2020;12:399.","journal-title":"Viruses"},{"key":"495_CR16","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1039\/D0AY02106G","volume":"13","author":"NS Al-Shakliah","year":"2021","unstructured":"Al-Shakliah NS, Attwa MW, AlRabiah H, Kadi AA. Identification and characterization of in vitro, in vivo, and reactive metabolites of tandutinib using liquid chromatography ion trap mass spectrometry. Anal Methods. 2021;13:399\u2013410.","journal-title":"Anal Methods"},{"key":"495_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11164-013-1177-1","volume":"41","author":"RA Al-Salahi","year":"2015","unstructured":"Al-Salahi RA, Al-Omar MA, Alswaidan I, Marzouk M, El-Senousy WM, Amr AE-GE. Antiviral activities of some synthesized methylsulfanyltriazoloquinazoline derivatives. Res Chem Intermed. 2015;41:151\u201361.","journal-title":"Res Chem Intermed"},{"key":"495_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2021.105157","volume":"160","author":"HA Abuelizz","year":"2021","unstructured":"Abuelizz HA, Marzouk M, Bakhiet A, Abdel-Aziz MM, Ezzeldin E, Rashid H, et al. In silico study and biological screening of benzoquinazolines as potential antimicrobial agents against methicillin-resistant Staphylococcus aureus, carbapenem-resistant Klebsiella pneumoniae, and fluconazole-resistant Candida albicans. Microb Pathog. 2021;160: 105157.","journal-title":"Microb Pathog"},{"key":"495_CR19","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.pharep.2019.04.003","volume":"71","author":"R Al-Salahi","year":"2019","unstructured":"Al-Salahi R, Taie HAA, Bakheit AH, Marzouk M, Almehizia AA, Herqash R, et al. Antioxidant activities and molecular docking of 2-thioxobenzo[g]quinazoline derivatives. Pharmacol Reports. 2019;71:695\u2013700. https:\/\/doi.org\/10.1016\/j.pharep.2019.04.003.","journal-title":"Pharmacol Reports"},{"key":"495_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2018.09.006","author":"AA Almehizia","year":"2019","unstructured":"Almehizia AA, Abuelizz HA, Taie HAA, ElHassane A, Marzouk M, Al-Salahi R. Investigation the antioxidant activity of benzo[g]triazoloquinazolines correlated with a DFT study. Saudi Pharm J. 2019. https:\/\/doi.org\/10.1016\/j.jsps.2018.09.006.","journal-title":"Saudi Pharm J"},{"key":"495_CR21","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/j.bmcl.2019.04.043","volume":"29","author":"R Al-Salahi","year":"2019","unstructured":"Al-Salahi R, Marzouk M, Abuelizz HA. Anti-HAV evaluation and molecular docking of newly synthesized 3-benzyl (phenethyl) benzo [g] quinazolines. Bioorg Med Chem Lett. 2019;29:1614\u20139.","journal-title":"Bioorg Med Chem Lett"},{"key":"495_CR22","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.4155\/fmc-2018-0141","volume":"10","author":"R Al-Salahi","year":"2018","unstructured":"Al-Salahi R, Ahmad R, Anouar E, Iwana Nor Azman NI, Marzouk M, Abuelizz HA. 3-Benzyl(phenethyl)-2-thioxobenzo[g]quinazolines as a new class of potent \u03b1-glucosidase inhibitors: Synthesis and molecular docking study. Future Med Chem. 2018;10:1889\u2013905. https:\/\/doi.org\/10.4155\/fmc-2018-0141.","journal-title":"Future Med Chem"},{"key":"495_CR23","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.jsps.2018.06.001","volume":"26","author":"R Al-Salahi","year":"2018","unstructured":"Al-Salahi R, Moustapha ME, Abuelizz HA, Alharthi AI, Alburikan KA, Ibrahim IT, et al. Radioiodination and biodistribution of newly synthesized 3-benzyl-2-([3-methoxybenzyl] thio) benzo [g] quinazolin-4-(3H)-one in tumor bearing mice. Saudi Pharm J. 2018;26:1120\u20136.","journal-title":"Saudi Pharm J"},{"key":"495_CR24","doi-asserted-by":"publisher","unstructured":"Abuelizz HA, Marzouk M, Bakheit AH, Al-Salahi R. Investigation of some benzoquinazoline and quinazoline derivatives as novel inhibitors of HCV-NS3\/4A protease: Biological, molecular docking and QSAR studies. RSC Adv 2020; doi: 10. https:\/\/doi.org\/10.1039\/d0ra05604a.","DOI":"10.1039\/d0ra05604a"},{"key":"495_CR25","doi-asserted-by":"publisher","first-page":"5944","DOI":"10.3390\/molecules25245944","volume":"25","author":"HA Abuelizz","year":"2020","unstructured":"Abuelizz HA, Marzouk M, Bakheit AH, Awad HM, Soltan MM, Naglah AM, et al. Antiproliferative and antiangiogenic properties of new VEGFR-2-targeting 2-thioxobenzo [g] quinazoline derivatives (In Vitro). Molecules. 2020;25:5944.","journal-title":"Molecules"},{"key":"495_CR26","doi-asserted-by":"publisher","unstructured":"Al-Salahi R, Abuelizz HA, El Dib R, Marzouk M, Alshammari MB. Antimicrobial activity of new 2-thioxo-benzo[g]quinazolin-4(3H)-one derivatives. Med Chem (Los Angeles) 2017; doi: https:\/\/doi.org\/10.2174\/1573406412666160610095706.","DOI":"10.2174\/1573406412666160610095706"},{"key":"495_CR27","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.3987\/COM-15-13282","volume":"91","author":"R Al-Salahi","year":"2015","unstructured":"Al-Salahi R, El Dib RA, Marzouk M. Synthesis and in vitro cytotoxicity evaluation of new 2-thioxo-benzo[g]quinazolin-4(3h)-one derivatives. Heterocycles. 2015;91:1735\u201351.","journal-title":"Heterocycles"},{"key":"495_CR28","doi-asserted-by":"crossref","unstructured":"Al-Salahi R, A Abuelizz H, Wadi M, A El Dib R, A Alotaibi M, Marzouk M. Antimicrobial activity of synthesized 2-methylthiobenzo [g][1, 2, 4]-triazolo [1, 5-a] quinazoline derivatives. Med Chem 2016;12:760\u2013766.","DOI":"10.2174\/1573406412666160502155106"},{"key":"495_CR29","doi-asserted-by":"publisher","unstructured":"Al-Salahi R, Abuelizz HA, Ghabbour HA, El-Dib R, Marzouk M. Molecular docking study and antiviral evaluation of 2-thioxo-benzo[g]quinazolin-4(3H)-one derivatives. Chem Cent J 2016; doi: https:\/\/doi.org\/10.1186\/s13065-016-0168-x.","DOI":"10.1186\/s13065-016-0168-x"},{"key":"495_CR30","first-page":"323","volume":"13","author":"CMO Sim\u00f5es","year":"1999","unstructured":"Sim\u00f5es CMO, Amoros M, Girre L. Mechanism of antiviral activity of triterpenoid saponins. Phyther Res An Int J Devoted to Pharmacol Toxicol Eval Nat Prod Deriv. 1999;13:323\u20138.","journal-title":"Phyther Res An Int J Devoted to Pharmacol Toxicol Eval Nat Prod Deriv"},{"key":"495_CR31","unstructured":"Walum E, Stenberg K, Jenssen D. Understanding cell toxicology. E. Horwood; 1990."},{"key":"495_CR32","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1080\/07328319808004686","volume":"17","author":"M Schmidtke","year":"1998","unstructured":"Schmidtke M, Knorre C, Blei L, Stelzner A, Birch-Hirschfeld E. Penetration and antiviral activity of Coxsackievirus B3 (CVB3)-specific phosphorothioate oligodeoxynucleotides (PS-ODN). Nucleosides Nucleotides. 1998;17:1557\u201366.","journal-title":"Nucleosides Nucleotides"},{"key":"495_CR33","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/0471721204.ch25","volume":"44","author":"E Krieger","year":"2003","unstructured":"Krieger E, Nabuurs SB, Vriend G. Homology modeling. Methods Biochem Anal. 2003;44:509\u201324.","journal-title":"Methods Biochem Anal"},{"key":"495_CR34","doi-asserted-by":"publisher","first-page":"W252","DOI":"10.1093\/nar\/gku340","volume":"42","author":"M Biasini","year":"2014","unstructured":"Biasini M, Bienert S, Waterhouse A, Arnold K, Studer G, Schmidt T, et al. SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res. 2014;42:W252\u20138.","journal-title":"Nucleic Acids Res"},{"key":"495_CR35","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/prot.21715","volume":"71","author":"P Benkert","year":"2008","unstructured":"Benkert P, Tosatto SCE, Schomburg D. QMEAN: A comprehensive scoring function for model quality assessment. Proteins Struct Funct Bioinforma. 2008;71:261\u201377.","journal-title":"Proteins Struct Funct Bioinforma"},{"key":"495_CR36","doi-asserted-by":"publisher","first-page":"W510","DOI":"10.1093\/nar\/gkp322","volume":"37","author":"P Benkert","year":"2009","unstructured":"Benkert P, K\u00fcnzli M, Schwede T. QMEAN server for protein model quality estimation. Nucleic Acids Res. 2009;37:W510\u20134.","journal-title":"Nucleic Acids Res"},{"key":"495_CR37","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1107\/S0021889892009944","volume":"26","author":"RA Laskowski","year":"1993","unstructured":"Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr. 1993;26:283\u201391.","journal-title":"J Appl Crystallogr"},{"key":"495_CR38","first-page":"1","volume":"86","author":"WF van Gunsteren","year":"1996","unstructured":"van Gunsteren WF, Billeter SR, Eising AA, H\u00fcnenberger PH, Kr\u00fcger P, Mark AE, et al. Biomolecular simulation: the GROMOS96 manual and user guide. Vdf Hochschulverlag AG an Der ETH Z\u00fcrich, Z\u00fcrich. 1996;86:1\u20131044.","journal-title":"Vdf Hochschulverlag AG an Der ETH Z\u00fcrich, Z\u00fcrich"},{"key":"495_CR39","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1002\/jcc.20289","volume":"26","author":"JC Phillips","year":"2005","unstructured":"Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E, et al. Scalable molecular dynamics with NAMD. J Comput Chem. 2005;26:1781\u2013802.","journal-title":"J Comput Chem"},{"key":"495_CR40","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1002\/jcc.20945","volume":"29","author":"S Jo","year":"2008","unstructured":"Jo S, Kim T, Iyer VG, Im W. CHARMM-GUI: a web-based graphical user interface for CHARMM. J Comput Chem. 2008;29:1859\u201365.","journal-title":"J Comput Chem"},{"key":"495_CR41","doi-asserted-by":"publisher","first-page":"3692","DOI":"10.1021\/acs.jpcb.6b01316","volume":"120","author":"S Boonstra","year":"2016","unstructured":"Boonstra S, Onck PR, van der Giessen E. CHARMM TIP3P water model suppresses peptide folding by solvating the unfolded state. J Phys Chem B. 2016;120:3692\u20138.","journal-title":"J Phys Chem B"},{"key":"495_CR42","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4155\/fmc-2020-0380","volume":"14","author":"AR Hakami","year":"2022","unstructured":"Hakami AR, Bakheit AH, Almehizia AA, Ghazwani MY. Selection of SARS-CoV-2 main protease inhibitor using structure-based virtual screening. Future Med Chem. 2022;14:61\u201379.","journal-title":"Future Med Chem"},{"key":"495_CR43","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1021\/acschemneuro.9b00696","volume":"11","author":"B Ji","year":"2020","unstructured":"Ji B, Liu S, He X, Man VH, Xie X-Q, Wang J. Prediction of the binding affinities and selectivity for CB1 and CB2 ligands using homology modeling, molecular docking, molecular dynamics simulations, and MM-PBSA binding free energy calculations. ACS Chem Neurosci. 2020;11:1139\u201358.","journal-title":"ACS Chem Neurosci"},{"key":"495_CR44","doi-asserted-by":"crossref","unstructured":"Cavasotto CN. Binding free energy calculation using quantum mechanics aimed for drug lead optimization. Quantum Mech Drug Discov 2020:257\u2013268.","DOI":"10.1007\/978-1-0716-0282-9_16"},{"key":"495_CR45","doi-asserted-by":"crossref","unstructured":"Miller III BR, McGee Jr TD, Swails JM, Homeyer N, Gohlke H, Roitberg AE. MMPBSA. py: an efficient program for end-state free energy calculations. J Chem Theory Comput 2012;8:3314\u20133321.","DOI":"10.1021\/ct300418h"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-023-00495-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-023-00495-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-023-00495-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T16:34:18Z","timestamp":1744216458000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-023-00495-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,21]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["495"],"URL":"https:\/\/doi.org\/10.1007\/s43440-023-00495-z","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,21]]},"assertion":[{"value":"1 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}